Your Search Returned 38 tagged news reports
A new inhaled medication has the potential to treat mild asthma and allergies by interrupting the production of an immune system protein that triggers allergic reactions, a new study reports. The drug, quilizumab, targets the blood cells that produce
Under the deal, AstraZeneca will pay Synairgen a $7.25m up-front fee and potential development, regulatory and commercial milestones of about $225m. Additionally, AstraZeneca will pay tiered royalties ranging from single-digit up to mid-teens on
Asthma is caused by inflammation of the air passages in the lungs...A new study by a team of scientists at King's College London also revealed the fact that Vitamin D, which is made by the body in sunlight, calms an "overactive" part of the immune
After a few days, she had been extubated and had acquired a new diagnosis: asthma. When she saw me in clinic, she felt better than she had when she had come to the hospital, but she continued to complain of shortness of breath and a severe cough.
Get tips on symptoms, medications and using an asthma action plan. Asthma in older children can interfere with sleep, school, sports and social activities. But proper asthma treatment in children can keep symptoms at bay. You and your child can
10 December 2013 0 View comments An English student has been forced to drop out of university because she has a potentially deadly allergy to books. Kirsty Ashman's severe allergies meant that grubby student accommodation and dusty lecture halls and
Centre for Integrative Medical Sciences and Keio University in Japan report that a type of lymphocytes called natural helper (NH) cells plays a critical role in corticosteroid resistance and demonstrate that the anti-psychotic drug Pimozide can be
13 editor Despite evidence that asthma can be effectively managed, not only asthma-related health literacy is very low in most settings but also quality-assured affordable essential medicines are very seldom available. With slow growth in awareness
Thursday Mar 7, 2013 A groundbreaking New Zealand asthma study using innovative local technology has found combination inhalers are more effective at preventing asthma attacks than the two inhalers doctors usually prescribe. The prestigious Lancet
Asthma patients typically use two inhaled drugs -- one a fast-acting "rescue inhaler " to stem attacks and another long-lasting one to prevent them. However, combining both in one inhaler may be best for some patients, two new studies suggest.